Table 4.
Vascular responses to a high sodium meal followed by the antioxidant cocktail/placebo.
| All subjects | Men | Women | |||||
|---|---|---|---|---|---|---|---|
| Time | PLA | AO | PLA | AO | PLA | AO | |
| FMD diameter change (%) | BSL | 6.7±0.5 | 6.3±0.5 | 5.8±0.6 | 5.8±0.6 | 7.4±0.7* | 6.9±0.7 |
| 60min | 6.4±0.6 | 6.5±0.6 | 5.1±0.7 | 4.5±0.5 | 7.6±0.8* | 8.4±0.8* | |
| 120min | 6.4±0.5 | 6.7±0.5 | 4.8±0.6 | 6.2±0.6 | 7.9±0.6* | 7.2±0.8 | |
| Baseline diameter (mm) | BSL | 3.84±0.09 | 3.83± 0.12 | 4.26±0.11 | 4.22±0.11 | 3.43±0.08* | 3.46±0.16* |
| 60min | 3.81±0.10 | 3.79±0.10 | 4.31±0.11 | 4.26±0.10 | 3.33±0.06* | 3.35±0.07* | |
| 120min | 3.86±0.10 | 3.73±0.09 | 4.26±0.12 | 4.16±0.10 | 3.47±0.08* | 3.32±0.08* | |
| Peak diameter (mm) | BSL | 4.09 ±0.10 | 4.06±0.12 | 4.50±0.11 | 4.45±0.11 | 3.69±0.10* | 3.69±0.16* |
| 60 min | 4.04±0.10 | 4.02±0.09 | 4.52±0.11 | 4.45±0.10 | 3.58±0.07* | 3.61±0.07* | |
| 120min | 4.10±0.09 | 3.97±0.10 | 4.46±0.12 | 4.41±0.10 | 3.75±0.09* | 3.55±0.09* | |
| FMD (mm Δ) | BSL | 0.25±0.02 | 0.23±0.01 | 0.24±0.02 | 0.24±0.02 | 0.26±0.03 | 0.23±0.02 |
| 60min | 0.23±0.02 | 0.23±0.02 | 0.21±0.03 | 0.20±0.02 | 0.25±0.03 | 0.26±0.02 | |
| 120min | 0.24±0.02 | 0.24±0.02 | 0.20±0.02 | 0.25±0.02 | 0.27±0.02 | 0.24±0.03 | |
| Shear rate (AUC) | BSL | 16,498±976 | 17,794±1,382 | 15,552±1,168 | 16,167±1,380 | 17,399±1,550 | 19,344±2,342 |
| 60min | 16,695±1,179 | 17,144±1,274 | 13,699±1,355 | 14,191±1,195 | 19,548±1,711* | 19,957±2,059* | |
| 120min | 16,276±1,316 | 15,837±1,079 | 14,394±1,664 | 12,970±952 | 18,067±1,982 | 18,567±1,720* | |
Values are means ± SEM.
p<0.05 Men vs. Women.
AO, antioxidant; AUC, area under the curve; BSL, baseline; PLA, placebo.